Sandeep Pallerla Selected Research

compound 18

2/2018	Design of cyclic and d-amino acids containing peptidomimetics for inhibition of protein-protein interactions of HER2-HER3.
9/2017	A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandeep Pallerla Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 01/2015
3	Lung Neoplasms (Lung Cancer) 02/2018 - 01/2015
2	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2017
2	Rheumatoid Arthritis 01/2018 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2016
1	Infections 01/2021

Drug/Important Bio-Agent (IBA)

3	PeptidomimeticsIBA 02/2018 - 01/2017
2	compound 18IBA 02/2018 - 09/2017
2	Peptides (Polypeptides)IBA 01/2018 - 01/2016
1	VaccinesIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Immunotoxins (Immunotoxin)IBA 01/2021
1	AntigensIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Cancer VaccinesIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2020
1	Amino Acids FDA Link 02/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	AnthracyclinesIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Immunomodulating AgentsIBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2015

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2015